ClinicalTrials.govpublic full text
Oral DLBS1033 as Adjunctive Therapy in Acute Ischemic Stroke: Impact on Inflammatory Biomarkers and Outcomes
ischemic stroke, acute, interleukin-6, ischemic stroke, treatment outcome, tumor necrosis factor-alpha, oral lumbrokinase dlbs1033, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 843689
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.